Perlegen Sciences, Inc. Fills out Leadership Team to Prepare for Multiple Personalized Medicine Programs

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Perlegen Sciences announced today the successful recruitment of three senior professionals to help position the company to execute an upcoming pipeline of genetic, drug response studies. A leader in discovering and understanding the role that human genetic variation plays in patients’ response to drugs, Perlegen applies next generation re-sequencing and SNP genotyping across the genomes of thousands of patients to determine those variations associated with given traits of interest.

MORE ON THIS TOPIC